androgenetic alopecia Clinical Trials

18 recruitingLast updated: June 18, 2026

There are 18 actively recruiting androgenetic alopecia clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1. Top locations include Atlanta, Georgia, United States, Austin, Texas, United States, Aventura, Florida, United States. Updated daily from ClinicalTrials.gov.


androgenetic alopecia Trials at a Glance

18 actively recruiting trials for androgenetic alopecia are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Atlanta, Austin, and Aventura. Lead sponsors running androgenetic alopecia studies include Industrial Farmacéutica Cantabria, S.A., Epibiotech, and EMS.

Browse androgenetic alopecia trials by phase

Treatments under study

About androgenetic alopecia Clinical Trials

Looking for clinical trials for androgenetic alopecia? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new androgenetic alopecia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about androgenetic alopecia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Not Applicable

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Scarring Alopeciaandrogenetic alopecia
Montefiore Medical Center10 enrolled1 locationNCT05460611
Recruiting
Phase 1Phase 2

Study of EPI-001 in Patients With Androgenetic Alopecia

androgenetic alopecia
Epibiotech42 enrolled1 locationNCT07618195
Recruiting
Phase 1Phase 2

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Androgenetic alopecia (AGA)Healthy Volunteers - Male and Female
Absci Pty Ltd.227 enrolled4 locationsNCT07317544
Recruiting
Not Applicable

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

Androgenetic alopecia (AGA)
Institute of Dermatology, Thailand80 enrolled2 locationsNCT07536100
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Female Pattern Baldnessandrogenetic alopecia
Industrial Farmacéutica Cantabria, S.A.520 enrolled13 locationsNCT05888922
Recruiting
Not Applicable

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

Androgenic alopeciaandrogenetic alopecia
Kasr El Aini Hospital25 enrolled1 locationNCT07563036
Recruiting
Phase 2

PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study

Androgenetic alopecia (AGA)
Nanfang Hospital, Southern Medical University76 enrolled1 locationNCT07335367
Recruiting
Phase 2

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

Androgenetic alopecia (AGA)
Shenzhen People's Hospital388 enrolled1 locationNCT07370519
Recruiting
Phase 1Phase 2

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

Androgenetic alopecia (AGA)
Olix Pharmaceuticals, Inc.158 enrolled1 locationNCT07327359
Recruiting
Phase 3

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

androgenetic alopecia
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.294 enrolled1 locationNCT07080931
Recruiting
Phase 1Phase 2

Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

androgenetic alopecia
PT. Prodia Stem Cell Indonesia40 enrolled1 locationNCT07429253
Recruiting
Phase 3

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

androgenetic alopecia
EMS190 enrolled1 locationNCT04594018
Recruiting
Phase 3

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

Androgenetic alopecia (AGA)Hair LossAGA+2 more
Veradermics, Inc.552 enrolled71 locationsNCT07146022
Recruiting
Phase 3

Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

Male Pattern Baldnessandrogenetic alopecia
Samson Clinical Operations Pty Ltd132 enrolled3 locationsNCT06924632
Recruiting
Not Applicable

Thulium Laser and Growth Factors for Androgenetic Alopecia

Androgenetic alopecia (AGA)
Universitätsklinikum Hamburg-Eppendorf30 enrolled1 locationNCT07079657
Recruiting
Early Phase 1

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

Androgenetic alopecia (AGA)
Shanghai Zhongshan Hospital30 enrolled1 locationNCT07012486
Recruiting
Not Applicable

Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers

androgenetic alopecia
Industrial Farmacéutica Cantabria, S.A.45 enrolled2 locationsNCT06841458
Recruiting
Not Applicable

Sham LaserCap vs. LaserCap SD vs. LaserCap HD+

androgenetic alopecia
University of Arizona50 enrolled1 locationNCT05365360